Skip to main content
. 2020 Oct 21;70(6):1130–1138. doi: 10.1136/gutjnl-2020-321956

Table 4.

Diagnostic accuracy of FIT for CRC and SBD at different cut-offs

Risk category FIT positivity Cut-off (µg/g) Sensitivity Specificity PPV NPV
≥2 37.2 CRC 97.0 (94.5 to 98.5) 64.9 (63.9 to 65.8) 8.7 (7.8 to 9.7) 99.8 (99.7 to 99.9)
HRA 65.8 (61.0 to 70.3) 64.1 (63.1 to 65.0) 7.6 (6.7 to 8.5) 97.7 (97.3 to 98.0)
IBD 73.1 (68.6 to 77.2) 64.4 (63.4 to 65.4) 8.5 (7.7 to 9.5) 98.1 (97.8 to 98.5)
SBD 77.1 (74.6 to 79.5) 68.2 (67.2 to 69.2) 24.8 (23.4 to 26.3) 95.6 (95.1 to 96.1)
≥10 19.0 CRC 90.9 (87.2 to 93.8) 83.5 (82.8 to 84.3) 16.1 (14.4 to 17.8) 99.6 (99.5 to 99.7)
HRA 45.4 (40.5 to 50.3) 82.2 (81.4 to 83.0) 10.3 (8.9 to 11.7) 97.1 (96.7 to 97.5)
IBD 57.8 (53.0 to 62.6) 82.8 (82.0 to 83.6) 13.3 (11.8 to 14.9) 97.7 (97.4 to 98.1)
SBD 62.6 (59.8 to 65.4) 87.0 (86.3 to 87.7) 39.6 (37.4 to 41.8) 94.5 (93.9 to 95.0)
≥150 7.6 CRC 70.8 (65.6 to 75.7) 94.6 (94.1 to 95.0) 31.1 (27.8 to 34.6) 98.9 (98.7 to 99.1)
HRA 22.1 (18.2 to 26.4) 93.0 (92.5 to 93.5) 12.4 (10.1 to 15.0) 96.4 (96.0 to 96.8)
IBD 36.8 (32.2 to 41.5) 93.7 (93.2 to 94.2) 21.0 (18.1 to 24.1) 97.0 (96.7 to 97.4)
SBD 41.0 (38.2 to 43.9) 96.9 (96.5 to 97.3) 64.5 (60.9 to 67.9) 92.4 (91.8 to 92.9)

95% CIs within brackets.

CRC, colorectal cancer; FIT, faecal immunochemical test; HRA, high-risk adenoma; IBD, inflammatory bowel disease; NPV, negative predictive value; PPV, positive predictive value; SBD, serious bowel disease.